期刊文献+

2005-2007年我院呼吸系统药物用药分析 被引量:2

下载PDF
导出
摘要 目的:客观评估我院呼吸系统药物应用现状及趋势。方法:调查统计本院2005-2007年的呼吸系统药物使用品种、购药金额,分析临床使用情况。结果:2005-2007年呼吸系统用药的销售金额总和及占总金额的比例呈增长趋势。祛痰药用药比例基本保持稳定,氨溴索用药金额一直排名第一,桃金娘及舍雷肽酶逐渐得到广泛应用。镇咳药的使用以中枢性镇咳药为主,复方福尔可定使用呈增长趋势。平喘药中白三烯受体拮抗剂用量呈现快速增长趋势。祛痰、镇咳类中草药制剂在儿科应用广泛。结论:我院呼吸系统用药金额增长,结构稳定,用药情况基本合理。
出处 《中国医药导报》 CAS 2008年第20期135-136,共2页 China Medical Herald
  • 相关文献

参考文献7

二级参考文献31

  • 1Straehler-Pohl HJ, Burmeister G. Use of Gelomyrtol forte in sinusitides A course study[J]. ZFA (Stuttgart). 1978, Apr 54:611-615.
  • 2Federspil P, Wulkow R, Zimmermann T. Effects of standardized Myrtol in therapy of acute sinusitis-results of a double-blind,randomized multicenter study compared with placebo[J]. Laryngorhinootologie. 1997, 76:23-27.
  • 3Matthys H, De Mey C, Carls C, et al. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. Cefuroxime and ambroxol[ J ]. Arzneimittelforschung,2000, 50:700-711.
  • 4Meister R, Witting T, Beuscher N, et al. Efficacy and Tolerability of Myrtol Standardized in Long-term Treatment of Chronic Bronchitis. A double-blind, placebo-controlled study. Study Group Investigators[J]. Arzneimttelforsc-hung, 1999, 49:351-358.
  • 5Ulmer WT, Scha D. Chronic obstructive bronchitis. Effect of Gelomrtol forte in a placebo-controlled double-blind study[J ].Fortschr Med. 1991, 109:547-550.
  • 6Sengespeik HC, Zimmermann T, Peiske C, et al. Myrtol Standardized in the Treatment of Acute and Chronic Respiratory Infections in Children/A multicenter postmarketing surveillance study[J]. Arzneimittelforsc-hung, 1998, 48:990-994.
  • 7Dorow P, Weiss Th, Felix R, et al. Effect of a Secretolytic and a Combination of Pinene, Limonene and Cineole on Mucociliary Clearance in Patients with Chronic Pulmonary Obstruction[J].Arzneim Forsch, 1987, 37:1378-1381.
  • 8Zimmermann Th, Seiberling M, Thomann P, et al. Evaluation of the Relative Bioavailability and the Pharmacokinetics of Myrtol Standardized[J]. Arzneim Forsch, 1995, 45 : 1198-1201.
  • 9Uehleke H, Brinkschulte-Freitas M. Oral toxicity of an essential oil from myrtle and adaptive liver stimulation[ J ]. Toxicology,(1979) 12(3) :335-342.
  • 10Gall H, Kaehler A, Peter RU. Anaphylactic shock reaction to dibutyl-phthalate-containing capsules[J]. Dermatology, 1999,199:169-170.

共引文献118

同被引文献23

  • 1高改兰,张小斌,王凤洋,李维娜,高小宁.沐舒坦治疗新生儿重症肺炎58例疗效观察[J].中国儿童保健杂志,2007,15(2):204-205. 被引量:15
  • 2于红,吴结苟,田春.盐酸氨溴索的临床应用及哲学思考[J].攀枝花学院学报,2007,24(3):100-102. 被引量:8
  • 3陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 4吉林省卫牛厅.《吉林省抗菌药物临床应用分级管理翻录(2012年版)》[S]吉林,2012.
  • 5国家药品不良反应监测中心.药品不良反应信息通报:第49期:警惕盐酸氨溴索注射剂的严重过敏反应[EB/OL].(2012-09-03)[2014-12-18].http://www.sda.gov.cn/WS01/CL0078/74641.html.
  • 6Brozek JL,Bousquet J,Baena-Cagnani CE,et al.Allergic rhinitis and its impact on asthma(ARIA)guidelines:2010revision[J].J Allergy Clin Immunol,2010,126:466.
  • 7Turato G,Barbato A,Baraldo S,et al.Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma[J].Am J Respir Crit Care Med,2008,178:476.
  • 8Schuh S,Reisman J,Alshehri M,et al.A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma[J].N Engl J Med,2000,343:689.
  • 9Berger WE,White MV,Rhinitis Study Group.Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine[J].Ann Allergy Asthma Immunol,2003,91:205.
  • 10陈伟,成诗明,王黎霞.1997-2008年全国传染病监测系统报告的肺结核发病情况分析[J].疾病监测,2009,24(11):878-881. 被引量:27

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部